|
RC3H1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.718230E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.062200E-02 |
| Normal-vs-Stage2 |
1.744020E-01 |
| Normal-vs-Stage3 |
2.945800E-02 |
| Normal-vs-Stage4 |
2.389400E-01 |
| Stage1-vs-Stage2 |
9.184200E-01 |
| Stage1-vs-Stage3 |
5.468000E-01 |
| Stage1-vs-Stage4 |
6.301800E-01 |
| Stage2-vs-Stage3 |
7.161800E-01 |
| Stage2-vs-Stage4 |
7.446400E-01 |
| Stage3-vs-Stage4 |
9.251600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.821970E-02 |
| Normal-vs-AfricanAmerican |
6.075900E-02 |
| Normal-vs-Asian |
6.162400E-03 |
| Caucasian-vs-AfricanAmerican |
9.441200E-01 |
| Caucasian-vs-Asian |
7.580000E-02 |
| AfricanAmerican-vs-Asian |
3.520600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.162100E-03 |
| Normal-vs-Female |
7.290600E-01 |
| Male-vs-Female |
4.036000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.923450E-01 |
| Normal-vs-Extreme_Weight |
6.156600E-04 |
| Normal-vs-Obese |
2.717000E-01 |
| Normal-vs-Extreme_Obese |
7.282000E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.710000E-01 |
| Normal_Weight-vs-Obese |
6.439000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.598000E-01 |
| Extreme_Weight-vs-Obese |
3.765500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.374800E-01 |
| Obese-vs-Extreme_Obese |
2.139400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.718800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.569600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.801900E-04 |
| Normal-vs-Age(81-100Yrs) |
1.636750E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.315400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.892100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.215800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.717500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.990300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.392800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.451230E-01 |
| Normal-VS-Type2 PRCC |
1.446800E-04 |
| Normal-VS-KIRP CIMP |
1.353840E-02 |
| Normal-VS-Unclassified PRCC |
6.741600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.302990E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.479600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.410800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.287200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.836200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.488800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.58720000001489E-06 |
| Normal-vs-N1 |
4.769400E-01 |
| Normal-vs-N2 |
2.136100E-02 |
| N0-vs-N1 |
4.650100E-02 |
| N0-vs-N2 |
9.150600E-01 |
| N1-vs-N2 |
3.972500E-02 |
|
|
